Equillium (EQ) Interest Expenses (2017 - 2026)
Equillium's (EQ) quarterly Interest Expenses came in at $10.6 million in Q1 2026, up 10989.58% year-on-year from N/an in Q1 2025, and up 27197.44% on a QoQ basis from $39000.0 in Q4 2025.
Equillium (EQ) Interest Expenses (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Interest Expenses data on file, last reported at $10.6 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 10989.58% year-over-year to $10.6 million in Q1 2026; TTM through Mar 2026 was $10.6 million, a 2260.53% increase from a year earlier, with the FY2025 full-year figure at $54.7 million, up 7.4% from the prior year.
- Interest Expenses for Q1 2026 stood at $10.6 million, up from $39000.0 in the prior quarter.
- Over the last five years, Interest Expenses for EQ reached as high as $13.6 million in Q1 2024 and fell as low as $39000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $2.2 million across 5 years, with a median of $271000.0 in 2022.
- Across the five-year window, Interest Expenses plunged 99.29% in 2025 and soared 10989.58% in 2026, its largest moves.
- Year by year, Interest Expenses stood at $271000.0 in 2022, then plunged by 37.64% to $169000.0 in 2023, then fell by 27.22% to $123000.0 in 2024, then plunged by 68.29% to $39000.0 in 2025, then jumped by 27197.44% to $10.6 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $10.6 million in Q1 2026, $39000.0 in Q4 2025, and $4.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - | 10.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.65 Mn |
| Mar 31, 2026 | 10.65 Mn |
| Dec 31, 2025 | 39,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Sep 30, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 96,000.00 |
| Mar 31, 2025 | 96,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 562,000.00 |
| Sep 30, 2024 | 562,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 13.57 Mn |
| Mar 31, 2024 | 13.57 Mn |
| Sep 30, 2023 | 169,000.00 |
| Sep 30, 2023 | 169,000.00 |
| Jun 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 1.15 Mn |